- We will send in 10–14 business days.
/images/books/2820401/9780128185506.jpg)
- Author: Kristine E Shields
- Publisher: Academic Press
- ISBN-10: 0128185503
- ISBN-13: 9780128185506
- Format: 15.2 x 22.9 x 1.3 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities.
Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.02:32:06
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Kristine E Shields
- Publisher: Academic Press
- ISBN-10: 0128185503
- ISBN-13: 9780128185506
- Format: 15.2 x 22.9 x 1.3 cm, softcover
- Language: English English
Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities.
Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.
Reviews